市场调查报告书
商品编码
1392190
软骨修復市场 - 按形态(基于细胞、非细胞)、按类型(透明软骨、纤维软骨)、按应用(膝关节、髋关节)、按最终用途(医院和诊所、门诊手术中心)-全球预测, 2023-2032Cartilage Repair Market - By Modality (Cell Based, Non-cell Based), By Type (Hyaline Cartilage, Fibrocartilage), By Application (Knee, Hip), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers) - Global Forecast, 2023-2032 |
由于运动相关损伤的增加以及随后对最佳恢復和关节功能的先进解决方案的需求,软骨修復市场规模预计从 2023 年到 2032 年将以超过 10% 的CAGR扩大。再生医学和外科技术的不断进步为运动员提供了创新的干预措施,以实现持续的表现。对运动相关伤害预防和综合復健的高度重视进一步推动了软骨修復疗法的采用。
此外,医疗机构、研究机构和产业参与者之间的合作和收购等持续业务策略的跳跃将促进创新软骨修復解决方案的开发和商业化,推动市场成长。举个例子,2023 年 11 月,施乐辉收购了 CartiHeal,该公司生产 Agili-C,一种用于膝盖软骨再生的尖端运动医学疗法。
软骨修復产业分为模式、类型、应用、最终用途和区域。
根据类型,纤维软骨修復市场将在 2022 年产生大量收入,预计 2023 年至 2032 年CAGR将达到 10.4%。关节损伤和退化性疾病盛行率的上升正在刺激有针对性的纤维软骨修復策略的发展。此外,对解决特定软骨修復挑战、提高患者治疗效果以及推动更广泛的骨科再生医学领域进步的坚定承诺将推动该细分市场的成长。
就最终用途而言,由于微创软骨修復技术的兴起,门诊手术中心(ASC)领域的软骨修復产业预计在 2023 年至 2032 年间实现 10.5% 的成长率。 ASC 为软骨修復手术提供了方便且经济高效的设定。此外,对减少住院治疗和加快康復时间的需求激增可能会促使患者更倾向于在 ASC 进行软骨修復治疗。
从地区来看,亚太地区软骨修復市场预计 2023 年至 2032 年CAGR将达到 12.4%。运动相关伤害的增加、人口老化的加剧以及对先进骨科治疗意识的不断增强,都推动了对软骨修復解决方案的需求。此外,再生医学和骨科技术的进步正在推动该地区创新软骨修復疗法的采用。
此外,专注于提高软骨修復材料效率的研究工作的激增可能会增强该地区的行业前景。例如,2023年5月,香港城市大学联同华润科技研究院、神州航太生物科技集团进行联合科学实验,测试新型软骨修復材料样本在外太空的效能。
Cartilage Repair Market size is estimated to expand at over 10% CAGR from 2023-2032, driven by the rise in sports-related injuries along with the subsequent need for advanced solutions for optimal recovery and joint function. Rising advances in regenerative medicine and surgical techniques offer innovative interventions to athletes for sustained performance. The higher emphasis on sports-related injury prevention and comprehensive rehabilitation is further fueling the adoption of cartilage repair therapies.
Moreover, the jump in ongoing business strategies, such as collaborations and acquisitions between healthcare institutions, research organizations, and industry players will facilitate the development and commercialization of innovative cartilage repair solutions, propelling the market growth. To cite an instance, in November 2023, Smith+Nephew acquired CartiHeal, the company producing Agili-C, a cutting-edge sports medicine treatment for knee cartilage regeneration.
The cartilage repair industry is segmented into modality, type, application, end-use, and region.
Based on type, the fibrocartilage repair market generated substantial revenue in 2022 and is projected to hit 10.4% CAGR from 2023-2032. The rising prevalence of joint injuries and degenerative conditions is spurring the development of targeted fibrocartilage repair strategies. Moreover, the strong commitment towards addressing specific cartilage repair challenges, enhancing the patient outcomes, and driving advancements in the broader field of orthopedic regenerative medicine will propel the segment growth.
In terms of end-use, the cartilage repair industry from the ambulatory surgical centers (ASCs) segment is set to witness 10.5% growth rate between 2023 and 2032 owing to the rise in minimally invasive cartilage repair techniques. ASCs offer a convenient and cost-effective setting for cartilage repair procedures. Furthermore, the surging demand for reduced hospitalization and quicker recovery times is likely to fuel the patient preference for cartilage repair treatment at ASCs.
Regionally, the Asia Pacific cartilage repair market is estimated to expand at 12.4% CAGR from 2023-2032. The increasing sports-related injuries, the rising aging population, and the growing awareness of advanced orthopedic treatments is boosting the demand for cartilage repair solutions. Additionally, the higher advancements in regenerative medicine and orthopedic technologies is fueling the adoption of innovative cartilage repair therapies in the region.
Moreover, the surge in research efforts focused on enhancing the efficiency of cartilage repair materials may augment the regional industry outlook. For instance, in May 2023, The City University of Hong Kong joined forces with the China Resources Research Institute of Science and Technology and the Shenzhou Space Biotechnology Group to launch joint scientific experiments to test samples of new cartilage repair materials for effectiveness in the outer space.